Over 50m people suffer from multimorbidity (PMM) in Europe. Recent reviews find that PMM experience a range of system and professional-related issues with care delivery. In part, this is because current investments in process-based delivery means delivering healthcare within single diagnoses tracks/silos. For PMMs this does not reflect real-world conditions. No technology is available today that enables the specific care, treatment, administration and support needed for this target group. Breakthrough solutions will classify the individual according to their co/multimorbidities and medications. But this needs to be developed in close dialogue between PMM, care providers and industry sectors based upon a strong demand driven approach in a PCP. Accordingly, the CareMatrix Buyers Group (SE, NO, ES) challenge the market to develop innovative technology that enables more predictive care and support benefits for PMM. This is achieved with 6 project objectives summarised as PCP: stakeholder engagement, roadmap, Call, implementation, next steps and; profiling and outreach via IFIC. The methodology can be summarised as PCP: framing actions (PCP preparation, use of UCD principles and practice); implementation actions (Phases 1-3 contract management, support, evaluation and testing) and Market Preparation actions (business development support for Phase 3 suppliers, standards, initial PPI preparation). Direct benefits include: • 20% reduction in time spent for visits to care facilities • Improvements from baseline in at least 75% of aspects of care as identified using PREM surveys • 50% fewer patient data-related incidents (increased patient safety) between organizations • No of clinical errors reduced by 30%; Underpinning the CareMatrix solution(s) with integrated innovation (supportive policy priorities, organisational and social innovations) will optimise the potential of those solutions to produce savings of 10% in health care expenditure for PMM.

This project is a preparatory action for creating innovation procurement policies and instruments that can be effective and sustainable at regional level, but also relevant at European level. The preparatory work will be achieved by using four European regions that cover the full range of innovation performances defined by the EC’s Regional Innovation Scoreboard as development sites: Murcia (ES), Skåne (SE), Bucharest-Ilfov (RO) and Oulu (FI). During the project, the project consortium will: 1. Gather information from i) regional public bodies in charge of innovation policies and funding instruments, and ii) innovation ecosystem players, which propose and execute projects, using state of the art learnings and best practices. 2. Analyse this information to produce a Joint Programme and four regional Action Plans to incorporate innovation procurement to each region’s policy and increase its impact by leveraging EU initiatives and funding. The PREPARE consortium will produce and widely disseminate added-value results, including a knowledge asset on the state of the art of innovation procurement and policy recommendations. Exploitation initiatives will deliver capacity building, policy promotion at EU, national and regional level and the engagement of a network of EU regions interested in leveraging public procurement instruments to foster impactful innovation.

The focus of Cross4Health is to move beyond the state-of-the-art practice of regional clusters to unlock the collaborative potential of the SMEs from Aerospace, Biotechnology, Energy, ICT and Medical Devices (ABEIM) sectors in generating innovative solutions, business models and work-flows that enhance patient-centered personalized care for societal challenges in health, delivered through the Medical Devices new emerging industry value chains. By providing a framework for a more structured cross-sectoral and cross-border collaboration, that manages all the complex reactions within the process, Cross4Health instantiates the mechanisms to ensure the long-term sustainability of the action. The main outcome of the Cross4Health project will be a portfolio of innovative services, processes and products conceived in an intelligent ‘plug-in’ platform for ABEIM stakeholders by high performance crossover teams. This will increase the competitiveness of the SMEs, advancing the positioning of European countries in this new emerging market. All these will be achieved by pursuing the following project objectives: • Establishing Open Innovation Spaces where all the involved parties set the priorities and the challenges. • Generating added value, leveraging expert knowledge, new partnerships and market support by providing targeted monetary (competitive grants) and non-monetary (innovation vouchers) support mechanisms. • Facilitating fast testing and business hypothesis validation via large-scale demonstrators. • Facilitating sustainability by validating complementary funding streams and alignment with RIS3 strategies. Cross4Health Vision is to work towards the osmosis of technologies, culture, teams and businesses among the selected sectors, tearing down the blocking barriers to realize significant advances in Health, growth and employment for new and/or improved products, services and processes.

In the medium to longer-term, the fiscal space that governments have to provide additional budgetary resources will shrink, including for healthcare. Our response is that it is better to pre-empt rather than repair i.e., to incentivise new ways of financing health promotion and disease prevention. The financing solution is smart capacitating investment. This means sharing risks and resources to invest at scale across multiple levels within health ecosystems generating sustainable returns and localised benefits. The specific objectives are: 1. Draw on available evidence to strengthen how smart capacitating investment is framed and communicated 2. Assess and enhance organisational readiness for testing SCI models in the regional test-beds 3. Develop and test business models that are compatible with smart capacitating investment 4. Develop and test novel finance models to determine which of the business models align with pre-defined contingencies for delivering smart capacitating investment 5. Develop and test a prototype collaborative platform for governing smart capacitating investment in health promotion and prevention. With an interdisciplinary approach we calibrate and harmonise 3 main work streams: developing functional prototype models of the anchoring concept (smart capacitating investment) [WP2-4]; iterative testing in real world environments (ES,DE,SE,UK initially with an Open Call for a 2nd tranche of transition and less developed regions) to show relevance in tax and insurance-based systems [WP5-6]; preparing a social franchising package for large-scale demonstration [WP7]. Underpinning these workstreams, we will also explore and test platform-based collaborative spaces for the involvement of resourced citizen panels and local communities in planning and investment decisions for interventions and services. The project generates concrete outcomes and impacts for further development and uptake of smart capacitating investment that disrupts state-of-the-art.

The objective is to create a network/community/ecosystem of procurers and relevant stakeholders in PPI. The idea is to empower all the actors involved in PPI through this network, focusing on the procurers. We need to attract both experienced procurers and not experienced procurers if we want to succeed in this. We will also need to analyse current barriers and needs of procurers, and then create and shared tools to facilitate PPI for all the actors involved.